| Low Tie Versus High Tie of the Inferior Mesenteric Vein During Colorectal Cancer Surgery: A Randomized Clinical Trial (NCT05411783) | San Carlo di Nancy Hospital | 2022-05-01 |
| Oncological Differences Between Transanal and Laparoscopic Total Mesorectal Excision for Rectal Cancer. (NCT05201885) | Yanhong Deng | 2022-01-15 |
| Bacteriological Differences Between Transanal and Laparoscopic Total Mesorectal Excision for Rectal Cancer. (NCT05201872) | Yanhong Deng | 2022-01-15 |
| Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes (NCT04907643) | Cedars-Sinai Medical Center | 2021-10-05 |
| Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer (NCT04963283) | University of Colorado, Denver | 2021-06-23 |
| Effects of Modified Precision Functional Sphincter-Preserving Surgery (PPS) on Ultralow Rectal Cancer (NCT05245565) | Shanghai 10th People's Hospital | 2021-05-01 |
| MRI Split Scar Sign as a Predictor to Complete Pathologic Response After Neoadjuvant Chemoradiation in Rectal Cancer (NCT04745091) | Alexandria University | 2021-02-01 |
| Patient-Derived Organoids for Rectal Cancer (NCT04371198) | Duke University | 2020-09-18 |
| The Role of Pelvic Peritonization in Laparoscopic or Robotic Low Anterior Resection (NCT03699761) | Southwest Hospital, China | 2020-09-01 |
| Neo-adjuvant Pembrolizumab and Radiotherapy in Localised MSS Rectal Cancer (NCT04109755) | University Hospital, Geneva | 2020-06-02 |
| A Cohort of Predictive Factor of Pathologic Complete Response After Preoperative Neoadjuvant in Rectum Cancer (NCT04443985) | Mahidol University | 2020-06-01 |
| Total Neoadjuvant Therapy Followed by 'Watch and Wait' Approach or Organ Preservation for Low-risk Rectal Cancer (NCT04405206) | Peking University Cancer Hospital & Institute | 2020-05-25 |
| Determining Early Development of Faecal Incontinence and Anorectal Muscle Function After Surgery for Rectal Cancer. (NCT03257332) | Slagelse Hospital | 2019-11-12 |
| Effectiveness and Implementation of mPATH-CRC (NCT03843957) | Wake Forest University Health Sciences | 2019-10-31 |
| Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer (NCT03573791) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2018-05-21 |
| Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery (NCT02997553) | Institut de Cancérologie de Lorraine | 2017-11-29 |
| Efficacy of Colonoscopy, Colon Capsule and Fecal Immunological Test for Colorectal Cancer Screening (NCT02738359) | Hôpital Edouard Herriot | 2017-11-03 |
| Effects of High-intensity Training Compared to Resistance Training in Cancer Patients Undergoing Radiotherapy (NCT03252821) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2017-08-15 |
| Project HERO: Health Empowerment & Recovery Outcomes (NCT03345563) | Rutgers, The State University of New Jersey | 2017-07-31 |
| Clinical Effect of Neoadjuvant Hierarchical Treatment Based on Chemotherapy (NCT03071198) | Harbin Medical University | 2017-03-01 |
| Removal Time of Urinary Catheter After Laparoscopic Anterior Resection of the Rectum (NCT03065855) | Peking Union Medical College Hospital | 2017-02-01 |
| Multimodal Narcotic Limited Perioperative Pain Control With Colorectal Surgery (NCT02958566) | University of Illinois College of Medicine at Peoria | 2017-01-01 |
| Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum (NCT02641691) | Washington University School of Medicine | 2016-05-27 |
| Phase I of SGM-101 in Patients With Cancer of the Colon, Rectum or Pancreas (NCT02973672) | Surgimab | 2016-01-01 |
| Robotic Low Rectum Anterior Resection (NCT04015804) | Institut du Cancer de Montpellier - Val d'Aurelle | 2015-03-01 |
| Effects of S-1 and Capecitabine on Coronary Artery Blood Flow (NCT02216149) | Heikki Joensuu | 2015-01-01 |
| Self-monitoring and Reminder Texts to Increase Physical Activity After Cancer: a Pilot Randomized Controlled Trial (NCT02966054) | University of California, San Francisco | 2014-08-01 |
| BASE HSP110 : A New Therapeutic Target and a New Marker for Prognosis of Type MSI Colorectal Cancer (NCT02458664) | Assistance Publique - Hôpitaux de Paris | 2013-11-01 |
| Engagement of Patients With Advanced Cancer (NCT02966509) | Stanford University | 2013-08-01 |
| The Value of Laparoscopic Ultrasound in Patients Undergoing Laparoscopic Resection for Cancer of the Colon or Rectum (NCT02079389) | Odense University Hospital | 2013-05-01 |
| Study of the Preservation of the Left Colic Artery on Rectum Cancer Surgery (NCT01979029) | Jian Suo | 2013-02-01 |
| A Lymph Node Metastasis Predictor (LN-MASTER) in Rectal Cancer (NCT05493930) | Peking Union Medical College | 2010-01-01 |
| Treatment of Patients With Advanced Rectum Cancer With Capecitabine and Oxaliplatin Before, Under and After Radiation and With Adding Cetuximab to K-RAS Wild-type Patients (NCT00964457) | Copenhagen University Hospital at Herlev | 2009-08-01 |
| Study of Neoadjuvant CT With Selective Radiotherapy in Patients With Intermediate-Risk Cancer Rectum (NCT00909987) | Grupo Espanol Multidisciplinario del Cancer Digestivo | 2009-03-01 |
| Evaluating Factors Affecting Survival in Colon and Rectum Cancer (NCT05388513) | Umraniye Education and Research Hospital | 2009-01-01 |
| Computed Tomography-guided Brachytherapy Plus Chemotherapy for Locally Recurrent Rectum Cancer (NCT02423226) | The First People's Hospital of Changzhou | 2008-10-01 |
| Rectal Study: Value of Repeated FDG-PET-CT Scans in Rectal Cancer (NCT00576563) | Maastricht Radiation Oncology | 2007-03-01 |
| Partnership for Healthy Seniors (NCT00379743) | Johns Hopkins Bloomberg School of Public Health | 2006-10-01 |
| Cancer Prevention and Treatment Among African American Older Adults: Treatment Trial (NCT00509444) | Johns Hopkins Bloomberg School of Public Health | 2006-10-01 |
| Safety Study of Rapamycin Administered Before and During Radiotherapy to Treat Rectum Cancer (NCT00409994) | Maastricht Radiation Oncology | 2006-09-01 |
| Irinotecan and Cetuximab for Colorectal Cancer as Second Line Therapy (NCT00336856) | University of Pittsburgh | 2006-06-01 |
| QoL of Colorectal Cancer Patients and Spouses (NCT04744792) | Cihangir Akyol | 2006-03-01 |